HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Robert A Koeppe Selected Research

Vesicular Acetylcholine Transport Proteins (Vesicular Acetylcholine Transporter)

1/2022Cholinergic brain network deficits associated with vestibular sensory conflict deficits in Parkinson's disease: correlation with postural and gait deficits.
1/2021Regional cerebral cholinergic nerve terminal integrity and cardinal motor features in Parkinson's disease.
1/2020Topography of Cholinergic Changes in Dementia With Lewy Bodies and Key Neural Network Hubs.
7/2017Normal Striatal Vesicular Acetylcholine Transporter Expression in Tourette Syndrome.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Robert A Koeppe Research Topics

Disease

33Alzheimer Disease (Alzheimer's Disease)
04/2022 - 12/2003
29Parkinson Disease (Parkinson's Disease)
01/2022 - 12/2003
21Dementia (Dementias)
01/2020 - 12/2003
15Cognitive Dysfunction
12/2015 - 05/2009
11Pain (Aches)
01/2019 - 06/2002
5Neurodegenerative Diseases (Neurodegenerative Disease)
01/2022 - 11/2006
5Migraine Disorders (Migraine)
01/2019 - 06/2014
4Atrophy
12/2015 - 08/2010
3Headache (Headaches)
01/2019 - 06/2014
3Movement Disorders (Movement Disorder)
04/2014 - 11/2006
2Hypokinesia (Bradykinesia)
01/2021 - 05/2013
2Tremor (Tremors)
01/2021 - 05/2013
2Disease Progression
01/2018 - 09/2015
2Hyperalgesia
04/2017 - 06/2014
2REM Sleep Behavior Disorder
02/2015 - 04/2012
2Leukoaraiosis
12/2014 - 05/2013
2Gliosarcoma
07/2013 - 03/2010
2Neoplasms (Cancer)
07/2013 - 03/2010
2Parkinsonian Disorders (Parkinsonism)
04/2012 - 11/2006
1Cardiomyopathies (Cardiomyopathy)
01/2022
1Opiate Overdose
03/2020
1Hallucinations (Hallucination)
01/2020
1Progressive Supranuclear Palsy (Steele Richardson Olszewski Syndrome)
01/2020
1Gastrointestinal Diseases (Functional Gastrointestinal Disorders)
10/2019
1Diarrhea
10/2019
1Tauopathies
10/2019
1Major Depressive Disorder (Major Depressive Disorders)
01/2019
1Mental Disorders (Mental Disorder)
01/2019
1Gliosis
12/2018
1Heart Failure
12/2018
1Tourette Syndrome (Tourette's Syndrome)
07/2017
1Heart Diseases (Heart Disease)
01/2017
1Disorders of Excessive Somnolence (Hypersomnia)
08/2016
1Cerebral Cortical Thinning
11/2013
1Prodromal Symptoms
01/2013
1Myalgia
08/2012
1Sleep Apnea Syndromes (Sleep Apnea)
01/2012
1Leukoencephalopathies
08/2011
1Frontotemporal Lobar Degeneration (Degeneration, Frontotemporal Lobar)
03/2011

Drug/Important Bio-Agent (IBA)

20Amyloid (Amyloid Fibrils)IBA
10/2019 - 05/2010
19Biomarkers (Surrogate Marker)IBA
10/2020 - 09/2006
18Cholinergic Agents (Cholinergics)IBA
01/2022 - 12/2003
13Opioid Analgesics (Opioids)IBA
01/2019 - 06/2002
13dihydrotetrabenazineIBA
12/2014 - 06/2004
9Dopamine (Intropin)FDA LinkGeneric
01/2022 - 10/2006
9Glucose (Dextrose)FDA LinkGeneric
11/2013 - 01/2008
8carfentanil (carfentanyl)IBA
01/2019 - 11/2003
7AcetylcholinesteraseIBA
10/2013 - 12/2003
6mu Opioid Receptors (mu Opioid Receptor)IBA
03/2020 - 06/2002
6Opioid Receptors (Opioid Receptor)IBA
01/2019 - 06/2002
62- (4'- (methylamino)phenyl)- 6- hydroxybenzothiazole (Pittsburgh compound B)IBA
01/2014 - 08/2010
6Vesicular Monoamine Transport Proteins (Vesicular Monoamine Transporter)IBA
05/2013 - 09/2006
5Neurotransmitter Agents (Neurotransmitter)IBA
04/2012 - 06/2002
4Vesicular Acetylcholine Transport Proteins (Vesicular Acetylcholine Transporter)IBA
01/2022 - 07/2017
4florbetapirIBA
10/2021 - 10/2012
4RacloprideIBA
04/2017 - 09/2007
4Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link
08/2012 - 02/2005
3Pharmaceutical PreparationsIBA
01/2022 - 01/2008
3fluoroethoxy-benzovesamicolIBA
01/2022 - 01/2020
3PropionatesIBA
10/2013 - 06/2010
3CarbonIBA
12/2012 - 02/2008
3Analgesics (Analgesic Drugs)IBA
02/2008 - 06/2002
27- (6- fluoropyridin- 3- yl)- 5H- pyrido(4,3- b)indoleIBA
04/2022 - 01/2020
2LigandsIBA
01/2022 - 12/2012
2Acetylcholine (Acetylcholine Chloride)FDA Link
01/2022 - 01/2006
2Apolipoproteins E (ApoE)IBA
12/2015 - 01/2013
2ApolipoproteinsIBA
12/2015 - 01/2013
2Serotonin (5 Hydroxytryptamine)IBA
12/2012 - 01/2012
2ButyrylcholinesteraseIBA
12/2006 - 01/2006
1Dopamine Agonists (Dopamine Agonist)IBA
01/2022
14- (N- methylamino)- 4'- (2- (2- (2- fluoroethoxy)ethoxy)ethoxy)stilbeneIBA
10/2021
1Cholinergic ReceptorsIBA
01/2021
1Cholinergic Antagonists (Anticholinergics)IBA
01/2021
1Receptor for Advanced Glycation End ProductsIBA
10/2020
1Naloxone (Narcan)FDA LinkGeneric
03/2020
1Phosphotransferases (Kinase)IBA
10/2019
1Prion ProteinsIBA
10/2019
1saracatinibIBA
10/2019
1Peptides (Polypeptides)IBA
10/2019
1tau Proteins (tau Protein)IBA
01/2019
1Fluorine-18IBA
01/2019
1Carbon-11IBA
01/2019
1Tetrabenazine (Nitoman)FDA Link
01/2019
1Monoamine Oxidase (MAO)IBA
12/2018
1Clarithromycin (Biaxin)FDA LinkGeneric
08/2016
1Apolipoprotein E4IBA
04/2015
1Deoxyglucose (2 Deoxy D glucose)IBA
11/2013
1SolutionsIBA
07/2013
1EmulsionsIBA
07/2013
1Levodopa (L Dopa)FDA LinkGeneric
05/2013
1Serotonin Plasma Membrane Transport Proteins (Serotonin Transporter)IBA
12/2012
13-hydroxyephedrineIBA
10/2012
13- amino- 4- (2- dimethylaminomethylphenylsulfanyl)benzonitrileIBA
01/2012
1Biological ProductsIBA
05/2011

Therapy/Procedure

17Denervation
01/2020 - 11/2006
6Sympathectomy (Sympathectomies)
01/2022 - 11/2006
5Therapeutics
12/2018 - 06/2005
2Activities of Daily Living (ADL)
10/2019 - 09/2006
2Analgesia
06/2014 - 02/2008
1Implantable Defibrillators (Implantable Cardioverter-Defibrillator)
12/2018